Showing results (11-20 of 220) with videos related to
Sort By:
Pageof 22
European Journal of Clinical Pharmacology|March 14, 2003
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban AustraliaChristopher Cutts, Susan E TettClinical Rheumatology|January 10, 2009
Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the marketNadia Barozzi, Susan E TettPharmacoepidemiology and Drug Safety|May 16, 2006
Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004Vivien Chan, Susan E TettPharmacoepidemiology and Drug Safety|July 20, 2007
What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?Nadia Barozzi, Susan E TettBMC Health Services Research|September 26, 2008
Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of AustraliaNadia Barozzi, Susan E TettThe Journal of Applied Psychology|June 20, 2003
A personality trait-based interactionist model of job performanceRobert P Tett, Dawn D BurnettAntimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infectionS Tett, S Moore, J RayClinical Pharmacokinetics|July 13, 2004
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationChristine E Staatz, Susan E TettClinical Pharmacokinetics|January 5, 2007
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipientsChristine E Staatz, Susan E TettClinical Pharmacokinetics|June 4, 2015
Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant PatientsChristine E Staatz, Susan E TettPageof 22